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Hemophagocytic Syndrome in a Patient with Acute 
Tubulointerstitial Nephritis Secondary to Hepatitis A Virus 
Infection
Hepatitis A virus (HAV) infection is generally a self-limited disease, but the infection in 
adults can be serious, to be often complicated by acute kidney injury (AKI) and rarely by 
virus-associated hemophagocytic syndrome (VAHS). Our patient, a 48-yr-old man, was 
diagnosed with HAV infection complicated by dialysis-dependent AKI. His kidney biopsy 
showed acute tubulointerstitial nephritis with massive infiltration of activated macrophages 
and T cells, and he progressively demonstrated features of VAHS. With hemodialysis and 
steroid treatment, he was successfully recovered. 
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Acute kidney injury often complicates hepatitis A virus (HAV) 
infection. An incidence between 3% and 5.7% has been report-
ed in retrospective studies (1, 2), and both acute tubular necro-
sis (ATN) and acute tubulointerstitial nephritis (ATIN) have been 
reported (1, 3). Hemophagocytic syndrome, a very rare compli-
cation of HAV infection, is characterized by abnormal activation 
of macrophages with subsequent hemophagocytosis, spleno-
megaly, fever, and cytopenia (4); hemophagocytic syndrome 
can also be complicated by multiple organ failure. Our patient 
developed dialysis-dependent acute kidney injury (AKI) sec-
ondary to HAV infection and progressively showed features of 
virus-associated hemophagocytic syndrome (VAHS), which 
was successfully treated by steroids. We suggest a possible link 
between ATIN that was characterized by macrophage and T 
cell infiltration and development of VAHS caused by HAV in-
fection. 
CASE REPORT
A 48-yr-old man was transferred to our hospital with the diag-
nosis of AKI due to HAV infection requiring dialysis on June 4, 
2009. He had been admitted to another hospital with general 
weakness and jaundice. The initial laboratory examination re-
vealed the presence of IgM anti-HAV antibody, aspartate trans-
aminase 1212 (5-45) IU/L, alanine transaminase 2,462 (10-40) 
IU/L, total bilirubin 7.8 (0.3-1.4) mg/dL, direct bilirubin 6.2 (0-
0.4) mg/dL, gamma-glutamyl transpeptidase 102 (0-39) IU/L, 
hemoglobin 14.4 (13.1-17.2) g/dL, white blood cell count 14,700 
(4,500-11,000)/μL, and platelet count 163,000 (150,000-400,000)/
μL. The blood urea nitrogen (BUN) and creatinine were 43.6 (7-
20) and 9.3 (0.7-1.3) mg/dL, respectively, and hemodialysis was 
started. He developed fever on day 4 before transfer and vanco-
mycin was administered for possible catheter-related bactere-
mia. Upon presentation to our hospital, he was markedly jaun-
diced, and complained of weakness, fever, and rash. The vital 
signs were as follows: blood pressure, 200/100 mmHg; pulse 
rate, 108 beats/min; respiratory rate, 24/min; and body temper-
ature, 38.1°C. There were no palpable lymph nodes. The BUN 
and creatinine levels rose to 85 and 15.2 mg/dL, respectively, 
and the total bilirubin level progressively increased to 21.8 mg/
dL, with a normal prothrombin time. Viral markers, including 
Ebstein-Barr virus (EBV) and cytomegalovirus, were negative; 
HAV was positive. Urinalysis showed dark-colored urine with 
2+ bilirubin, a trace of blood, and 1+ proteinuria. A 24-hr urine 
test revealed albuminuria (197.2 mg). The daily urine output 
was maintained at 1,500-2,000 mL with furosemide. A chest 
roentgenogram initially showed pulmonary congestion with a 
bilateral pleural effusion that was improved by furosemide. Ab-
dominal ultrasonography showed normal sized kidneys with 
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day, a kidney biopsy was performed and showed a diffusely 
edematous interstitium with infiltration of inflammatory cells 
and severely damaged tubules, findings which were compatible 
with ATIN. An immunohistochemical study identified the infil-
trating cells as predominantly CD3
+ T cells and CD68
+ activated 
macrophages (Fig. 1). The glomeruli were relatively well-pre-
served. On the 8th hospital day, consolidation in both upper 
lobes developed. All microbiological culture studies were nega-
tive and no endobronchial lesions were detected. Despite cath-
eter exchange and empirical antibiotics, a high fever, consolida-
tion, and rash persisted. With hemodialysis and supportive care, 
liver and kidney dysfunction gradually improved, while anemia 
worsened and leucopenia and thrombocytopenia developed; 
the hemoglobin was 7.4 g/dL (hematocrit, 22.2%), the absolute 
neutrophil count was 130/μL, and the platelet count was 141,000/ 
μL. Granulocyte-colony stimulating factor (G-CSF) was given. 
A bone marrow biopsy revealed a normocellular marrow with 
occasional hemophagocytosis (Fig. 2); there was no evidence of 
malignancy. The ferritin level was 2678 (17-390) ng/mL, the tri-
glycerides were 493 (55-327) mg/dL, and the fibrinogen was 
557 (225-457) mg/dL. VAHS was highly suspected and steroids 
were added to the treatment regimen. Upon steroid treatment, 
the fever, rash, and bilateral consolidation rapidly subsided. 
Hemodialysis was stopped after 13 dialysis sessions and renal 
function remained stable with a serum creatinine level of 1.7 
mg/dL. He was discharged on a steroid taper in the outpatient 
clinic. The creatinine level declined to 1.3 mg/dL about 1 month 
later.
 
Fig. 1. Histopathological microscopy of the kidney biopsy. (A) Under light microscopy, 
diffuse edematous interstitium with damaged tubules and infiltration of inflammatory 
cells are shown. (H&E stain, ×100) (B, C) Immunohistochemistry. Diffuse and patchy 




Fig. 2. Hemophagocytosis (arrow) on smears of bone marrow aspiration.Cho E, et al.  •  Hemophagocytic Syndrome in Hepatitis A Associated ATIN
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DISCUSSION
HAV infection is generally self-limiting, but it can cause serious 
morbidity, such as AKI and occasional mortality (3). Although 
not frequently reported, HAV infection is also associated with 
hematologic complications, including VAHS (5). Hemophago-
cytic syndrome (HPS) is a rare, but potentially fatal disease. HPS 
is characterized by impaired function of NK and cytotoxic T cells, 
resulting in uncontrolled and ineffective immune activation, and 
leading to cellular damage as well as proliferation of benign mac-
rophages with hemophagocytosis (6, 7). HPS is divided into 
primary and secondary forms. EBV is the most common trigger-
ing agent and herpes infection is responsible for >50% of second-
ary VAHS cases (8). HAV is known to be associated with VAHS, 
but only 14 cases have been reported (4, 9). 
  The following diagnostic guidelines for VAHS were first pro-
posed in 1991 by the Histiocyte Society and updated in 2004 (10): 
1) fever, 2) splenomegaly, 3) cytopenia (≥2 of 3 lineages), 4) hy-
pertriglyceridemia (≥265 mg/dL) and/or hypofibrinogenemia 
(≤150 mg/dL), 5) hemophagocytosis in the bone marrow, spleen, 
or lymph nodes, without evidence of malignancy, 6) low or ab-
sent NK cell cytotoxicity, 7) hyperferritinemia (≥500 ng/mL), 
and 8) elevated soluble CD 25 (IL-2Rα chain ≥2,400 IU/mL). 
HPS is defined by the presence of 5 of the 8 criteria. Fever and 
splenomegaly are main clinical features and jaundice, hepato-
megaly, lymphadenopathy, rash, and lung infiltration are also 
common (7). Our patient met 6 of the 8 criteria (fever, spleno-
megaly, cytopenia, hypertriglyceridemia, hemophagocytosis in 
BM, and hyperferritinemia). The diagnosis of VAHS was delayed 
until the development of marked cytopenia in the current case. 
On kidney biopsy, interstitial mononuclear cells were identified 
to be mostly T lymphocytes and macrophages. Although an oc-
casional association of HAV with ATN or ATIN has been report-
ed, the precise pathogenic mechanisms are unknown, partly 
due to the rarity of kidney biopsies or immunohistochemical 
studies. HPS is also associated with diverse renal manifestations. 
Karras et al. (8) suggested that the possible mechanism of AKI 
in HPS was direct toxicity of pro-inflammatory cytokines (IL-6 
and TNF-α) on kidney tubular cells. In our case of pathological-
ly-confirmed ATIN due to HAV infection in which the hospital 
course was complicated by HPS, we observed massive kidney 
infiltration of activated macrophages and T cells. The role of 
macrophages or T cells in an animal model of AKI is well-known 
and is thought to contribute to renal dysfunction. However, 
whether the kidney infiltration in this case was specific to ATIN 
caused by HAV or was secondary to concurrent VAHS is un-
known. The number of interstitial CD68
+ macrophages or CD3
+ 
T cells in the current case was much higher than those of other 
kidney biopsy specimens from patients with HAV complicated 
by AKI (data not shown). Therefore, massive interstitial infiltra-
tion of macrophages and T cells in the kidney is likely to be as-
sociated with HPS. 
  Even though there are no randomized controlled trials ad-
dressing the treatment modalities for this rare HPS, patients are 
often started on corticosteroids with or without intravenous gam-
ma-globulin, as well as supportive care and treatment for the 
underlying infection. In addition, cytotoxic drugs, such as eto-
poside and cyclosporine, have been used and recent reports 
support the safety of G-CSF in patients with severe neutrope-
nia. Bone marrow transplantation can also save a life in severe 
cases. G-CSF and steroids were administered to our patient and 
clinical features, such as cytopenia, fever, rash, and pulmonary 
infiltrates, recovered rapidly. 
  Herein we have reported a case of ATIN secondary to HAV 
infection characterized by kidney infiltration of activated mac-
rophages and T cells in which the clinical course was compli-
cated by VAHS, suggesting a possible link between macrophage- 
and T cell-predominant ATIN and VAHS caused by HAV infec-
tion. In  addition, when unusual symptoms, such as persistent 
fever and cytopenia, develop in patients with HAV infection, 
concurrent HPS should be considered.
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